Elastin-like polypeptides and their applications in anticancer drug delivery systems: A review

Drug Delivery

Volumn 22, Issue 2, 2015, Pages 156-167

  Saxena, Rubha ^a   Nanjan, Moola Joghee ^a  

^a JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH   (India)

Author keywords

Cancer chemotherapy; Drug delivery; Drug targeting; Elastin; Elastin like polypeptides

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; ASPARAGINYLGLYCYLARGININE; BIOPOLYMER; CAMPTOTHECIN; CELL PENETRATING PEPTIDE; COLLAGEN; COPOLYMER; CYTOTOXIC AGENT; DEXAMETHASONE SODIUM PHOSPHATE; DOXORUBICIN; DOXYCYCLINE; DRUG CARRIER; ELASTIN; ELASTIN LIKE POLYPEPTIDE; GELDANAMYCIN; LACTOFERRIN; LIPOSOME; MELPHALAN; MULTIDRUG RESISTANCE PROTEIN; N (2 HYDROXYPROPYL)METHACRYLAMIDE; NANOPARTICLE; PACLITAXEL; PENETRATIN; PEPTIDE DERIVATIVE; POLY(N ISOPROPYLACRYLAMIDE COACRYLAMIDE); POLYPEPTIDE; RADIOISOTOPE; RAPAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; NANOMATERIAL; OLIGOPEPTIDE; PEPTIDE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

CELLULAR DISTRIBUTION; CHEMICAL MODIFICATION; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG SYNTHESIS; DRUG TARGETING; ENCAPSULATION; GENETIC ENGINEERING; HUMAN; INVERSE TEMPERATURE TRANSITION; MACROMOLECULE; MOLECULAR WEIGHT; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; REVIEW; TEMPERATURE SENSITIVITY; TRANSITION TEMPERATURE; ANIMAL; CHEMISTRY; GENETICS; HEAT; METABOLISM; NANOTECHNOLOGY; PHARMACEUTICS; PROTEIN CONFORMATION; PROTEIN ENGINEERING; SOLUBILITY; SYNTHESIS; TRENDS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOPHARMACEUTICS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ELASTIN; HOT TEMPERATURE; HUMANS; MOLECULAR WEIGHT; NANOSTRUCTURES; NANOTECHNOLOGY; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; SOLUBILITY;

EID: 84921686503     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.853210     Document Type: Review

References (78)

1. Abuchowski A, McCoy JR, Palczuk NC, et al. (1977). Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J Biol Chem 252:3582-6.
2. Arkin H, Bilsel M. (2010). How conformational transition depends on hydrophobicity of elastin-like polypeptides. Eur Phys J E Soft Matter 31:327-32.
3. Atkins JH, Gershell LJ. (2002). Selective anticancer drugs. Nat Rev Drug Discov 1:491-2.
4. Bidwell III GL, Davis AN, Fokt I, et al. (2007). A thermally targeted elastin like polypeptide doxorubicin conjugate overcomes drug resistance. Invest New Drugs 25:313-26.
5. Bidwell III GL, Perkins E, Hughes J, et al. (2013). Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model. PLoS One 8:e55104.
6. Bidwell III GL, Raucher D. (2005). Application of thermally responsive polypeptide directed against c-Myc transcriptional function for cancer therapy. Mol Cancer Ther 4:1076-85.
7. Bidwell III GL, Raucher D. (2010). Cell penetrating elastin-like polypeptides for therapeutic peptide delivery. Adv Drug Deliv Rev 62:1486-96.
8. Callahan DJ, Liu W, Li X, et al. (2012). Triple stimulus responsive polypeptide nanoparticles that enhance intratumoral spatial distribution. Nano Lett 12:2165-70.
9. Cappello J, Crissman JW, Crissman M, et al. (1998). In-situ self assembling protein polymer gel systems for administration, delivery and release of drugs. J Control Release 53:105-17.
10. Castiglione-Morelli A, Scopa A, Tamburro AM, Guantieri V. (1990). Spectroscopic studies on elastin like synthetic polypeptides. Int J Biol Macromol 12:363-8.
11. Chabner BA, Longo DL. (2001). Cancer chemotherapy and biotherapy: principles and practice. 3rd ed. Philadelphia, New York: Lippincott Williams & Wilkins.
12. Chen Y, Youn P, Furgeson DY. (2011). Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers. J Control Release 155:175-83.
13. Chilkoti A, Dreher MR, Meyer DE. (2002a). Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Deliv Rev 54:1093-111.
14. Chilkoti A, Dreher MR, Meyer DE, Raucher D. (2002b). Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 54:613-30.
15. Chow D, Nunalee ML, Lim DW, et al. (2008). Peptide-based Biopolymers in Biomedicine and Biotechnology. Mater Sci Eng R Rep 62:125-55.
16. Chung MI, Miao M, Stahl RJ, et al. (2006). Sequences and domain structure of mammalian, avian, amphibian and teleost tropoelastins: clues to the evolutionary history of elastins. Matrix Biol 25:492-504.
17. Daamen WF, Veerkamp JH, Van Hest JC, Van Kuppevelt TH. (2007). Elastin as a biomaterial for tissue engineering. Biomaterials 28:4378-98.
18. De Duve C, De Barsy T, Poole B, et al. (1974). Lysosomotropic agents. Biochem Pharmacol 23:2495-531.
19. Dreher MR, Raucher D, Balu N, et al. (2003). Evaluation of an elastin like polypeptide-doxorubicin conjugate for cancer therapy. J Control Release 91:31-43.
20. Dreher MR, Liu W, Michelich CR, et al. (2007). Thermal cycling enhances the accumulation of a temperature sensitive biopolymer in solid tumor. Cancer Res 67:4418-24.
21. Duncan R. (1992). Drug-polymer conjugate: potential for improved chemotherapy. Anticancer Drugs 3:175-210.
22. Duncan R. (2006). Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6:688-701.
23. Duncan R. (2009). Development of HPMA copolymer anticancer conjugates: clinical experience and lessons learnt. Adv Drug Deliv Rev 61:1131-48.
24. Duncan R, Kopecek J. (1984). Soluble synthetic polymers as potential drug carriers. Adv Polym Sci 57:51-101.
25. Duncan R, Seymour LW, O'Hare KB, et al. (1992). Preclinical evaluation of polymer bound doxorubicin. J Control Release 19:331-46.
26. Duncan R, Vicent MJ. (2013). Polymer therapeutics-prospects for 21st century: the end of the beginning. Adv Drug Deliv Rev 65:60-70.
27. Fujiwara K, Watanabe T. (1990). Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn 40:79-84.
28. Furgeson DY, Dreher MR, Chilkoti A. (2006). Structural optimization of a small Doxorubicin polypeptide conjugate for thermally targeted delivery to solid tumors. J Control Release 110:362-9.
29. He D, Chung M, Chan E, et al. (2007). Comparative genomics of elastins: sequence analysis of a highly repetitive protein. Matrix Biol 26:524-40.
30. Herrero-Vanrell R, Rincon AC, Alonso M, et al. (2005). Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release. J Control Release 102:113-22.
31. Huang PS, Oliff A. (2001). Drug-targeting strategies in cancer therapy. Curr Opin Genet Dev 11:104-10.
32. Jain RK. (1987). Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6:559-93.
33. Jain RK. (1989). Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81:570-6.
34. Jain RK. (2001). Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46:149-68.
35. Jensen SA, Vrhovski B, Weiss AS. (2000). Domain 26 of tropoelastin plays a dominant role in association by coacervation. J Biol Chem 275:28449-54.
36. Kaufmann D, Weberskirch R. (2006). Efficient synthesis of protein drug conjugates using a functionalizable recombinant elastin mimetic polypeptides. Macromol Biosci 6:952-8.
37. Li B, Alonoso DO, Daggett V. (2001). The molecular basis for the inverse temperature transition of elastin. J Mol Biol 305:581-92.
38. Liu W, Dreher MR, Furgeson DY, et al. (2006). Tumor accumulation, degradation and pharmacokinetics of elastin like polypeptides in nude mice. J Control Release 116:170-8.
39. Liu W, Mackay JA, Dreher MR, et al. (2010). Injectable intratumoral depot of thermally responsive polypeptideradionuclide conjugates delays tumor progression in a mouse model. J Control Release 144:2-9.
40. MacEwan SR, Callahan DJ, Chilkoti A. (2010). Stimulus responsive macromolecule and nanoparticles for cancer drug delivery. Nanomedicine (Lond) 5:793-806.
41. MacEwan SR, Chilkoti A. (2012). Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake. Nano Lett 12:3322-8.
42. Mackay JA, Chen M, McDaniel JR, et al. (2009). Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumors after a single injection. Nat Mater 8:993-9.
43. Mackay JA, Chilkoti A. (2008). Temperature sensitive peptides: engineering hyperthermia-directed therapeutics. Int J Hyperthermia 24:483-95.
44. Maeda H, Bharate GY, Daruwalla J. (2009). Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71:409-19.
45. Massodi I, Bidwell III GL, Davis A, et al. (2009a). Inhibition of ovarian cancer cell metastasis by a fusion polypeptide Tat-ELP. Clin Exp Metastasis 26:251-60.
46. Massodi I, Thomas E, Raucher D. (2009b). Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. Molecules 14:1999-2015.
47. Massodi I, Moktan S, Rawat A, et al. (2010). Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier. Int J Cancer 126:533-44.
48. Matsumura Y, Maeda A. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387-92.
49. McDaniel JR, Callahan DJ, Chilkoti A. (2010). Drug delivery to solid tumors by elastin-like polypeptides. Adv Drug Deliv Rev 62:1456-67.
50. McDaniel JR, MacEwan SR, Dewhirst M, Chilkoti A. (2012). Doxorubicin conjugated chimeric polypeptide nanoparticles that respond to mild hyperthermia. J Control Release 159:362-7.
51. Meyer DE, Chilkoti A. (2002). Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 3:357-67.
52. Meyer DE, Kong GA, Dewhirst MW, et al. (2001a). Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 61:1548-54.
53. Meyer DE, Shin BC, Kong GA, et al. (2001b). Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 74:213-24.
54. Moktan S, Perkins E, Kratz F, Raucher D. (2012). Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo. Mol Cancer Ther 11:1547-56.
55. Moses MA, Brem H, Langer R. (2003). Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 4:337-41.
56. Muiznieks LD, Weiss AS, Keeley FW. (2010). Structural disorder and dynamics of elastin. Biochem Cell Biol 88:239-50.
57. Na K, Lee SA, Jung SH, et al. (2012). Elastin-like polypeptide modified liposomes for enhancing cellular uptake into tumor cells. Colloids Surf B Biointerfaces 91:130-6.
58. Nakayama M, Okano T. (2011). Multi-targeting cancer chemotherapy using temperature-responsive drug carrier system. React Funct Polym 71:235-44.
59. Nicolini C, Ravindra R, Ludolph B, Winter R. (2004). Characterization of the temperature- and pressure-induced inverse and reentrant transition of the minimum elastin-like polypeptide GVG(VPGVG) by DSC, PPC, CD, and FT-IR spectroscopy. Biophys J 86:1385-92.
60. Nitta SK, Numata K. (2013). Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci 14:1629-54.
61. Patel NU, Purser CA, Baker RC, Janorkar AV. (2013). Effect of processing temperature on the morphology and drug-release characteristics of elastin-like polypeptide-collagen composite coatings. Biomacromolecules 14:2891-9.
62. Ponce AM, Vujaskovic Z, Yuan F, et al. (2006). Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 22:205-13.
63. Rapaka RS, Urry DW. (1978). Coacervation of sequential polypeptide models of tropoelastin. synthesis of H-(Val-Ala-Pro-Gly)n-Val-OMe and H-(Val-Pro-Gly-Gly)n-Val-OMe. Int J Pept Protein Res 11:97-108.
64. Raucher D, Chilkoti A. (2001). Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition. Cancer Res 61:7163-70.
65. Reiersen H, Clarke AR, Rees AR. (1998). Short elastin like peptides exhibit the same temperature induced structural transitions as elastin polymers: implication of protein engineering. J Mol Biol 283:255-64.
66. Ringsdorf H. (1975). Structure and properties of pharmacologically active polymers. J Polym Sci Polym Symp 51:135-53.
67. Rousseau RE, Schreiner E, Kohlmeyer A, Marx D. (2004). Temperature dependent conformational transitions and hydrogen bond dynamics of the elastin like octapeptide GVG(VPGVG): a molecular dynamics study. Biophys J 86:1393-407.
68. Shah M, Hsueh PY, Sun G, et al. (2012). Biodegradation of elastin-like polypeptide nanoparticles. Protein Sci 21:743-50.
69. Shi P, Aluri S, Lin YA, et al. (2013). Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo. J Control Release 171:330-8.
70. Simnick AJ, Amiram M, Liu W, et al. (2011). In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide. J Control Release 155:144-51.
71. Toonkool P, Jensen SA, Maxwell AL, Weiss AS. (2001). Hydrophobic domains of human Tropoelastin interact in a context-dependent manner. J Biol Chem 276:44575-80.
72. Urry DW. (1992). Free energy transduction in polypeptides and proteins based on inverse temperature transition. Prog Biophys Mol Biol 57:23-57.
73. Urry DW. (1997). Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J Phys Chem B 101:11007-28.
74. Urry DW, Parker TM, Reid MC, Gowda DC. (1991). Biocompatibility of the bioelastic material, poly(GVGVP) and its gamma irradiation cross-linked matrix-summary of generic biological test-results. J Bioact Compat Polym 6:263-82.
75. Vrhovski B, Weiss AS. (1998). Biochemistry of Tropoelastin. Eur J Biochem 258:1-18.
76. Walker L, Perkins E, Kratz F, Raucher D. (2012). Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative. Int J Pharm 436:825-32.
77. Wu Y, MacKay JA, McDaniel JR, et al. (2009). Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying. Biomacromolecules 10:19-24.
78. Yuan F, Dellian M, Fukumura D, et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752-6.